Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 1
2022 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Global Prevalence of Colistin Resistance in Klebsiella pneumoniae from Bloodstream Infection: A Systematic Review and Meta-Analysis.
Uzairue LI, Rabaan AA, Adewumi FA, Okolie OJ, Folorunso JB, Bakhrebah MA, Garout M, Alfouzan WA, Halwani MA, Alamri AA, Halawani SA, Alshahrani FS, Hasan A, Mutair AA, Alhumaid S, Etafo J, Utip I, Odoh IM, Uwaezuoke NS. Uzairue LI, et al. Among authors: etafo j. Pathogens. 2022 Sep 24;11(10):1092. doi: 10.3390/pathogens11101092. Pathogens. 2022. PMID: 36297149 Free PMC article. Review.
Establishment of a Lassa Fever Specimen Biobank in Nigeria.
Chi HF, Etafo J, Fonkeng F, Olufunke GB, Ireneh R, Abejegah C, Owhin S, Somiari S, Vessière A, Bausch DG, El Idrissi I, Fransman W, Kelly-Cirino C, Agogo E, Emperador DM, Adedosu NA. Chi HF, et al. Among authors: etafo j. Am J Trop Med Hyg. 2025 May 27;113(2):382-386. doi: 10.4269/ajtmh.24-0527. Print 2025 Aug 6. Am J Trop Med Hyg. 2025. PMID: 40425001 Free PMC article.
Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.
Heinrich ML, Boisen ML, Nelson DKS, Bush DJ, Cross RW, Koval AP, Hoffmann AR, Beddingfield BJ, Hastie KM, Rowland MM, Aimukanova I, Koval S, Lathigra R, Borisevich V, Momoh M, Sandi JD, Goba A, Odia L, Baimba F, Aiyepada JO, Ebo B, Eromon P, Ugwu C, Folarin O, Olumade T, Onyechi MN, Etafo J, Adeyemi R, Ella EE, Aminu M, Gomerep SS, Eke MA, Ogunsanya O, Akpede GO, Asogun DO, Okogbenin SA, Okokhere PO, Holst J, Shaffer JG, Schieffelin JS, Geisbert TW, Saphire EO, Happi CT, Grant DS, Garry RF, Branco LM. Heinrich ML, et al. Among authors: etafo j. Sci Rep. 2020 Sep 29;10(1):16030. doi: 10.1038/s41598-020-72539-w. Sci Rep. 2020. PMID: 32994446 Free PMC article.
Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study.
Duvignaud A, Jaspard M, Etafo IC, Gabillard D, Serra B, Abejegah C, le Gal C, Abidoye AT, Doutchi M, Owhin S, Séri B, Vihundira JK, Bérerd-Camara M, Schaeffer J, Danet N, Augier A, Ogbaini-Emovon E, Salam AP, Ahmed LA, Duraffour S, Horby P, Günther S, Adedosu AN, Ayodeji OO, Anglaret X, Malvy D; LASCOPE study group. Duvignaud A, et al. Lancet Glob Health. 2021 Apr;9(4):e469-e478. doi: 10.1016/S2214-109X(20)30518-0. Lancet Glob Health. 2021. PMID: 33740408 Free PMC article.
Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE).
Duvignaud A, Jaspard M, Etafo IC, Serra B, Abejegah C, Gabillard D, Doutchi M, Alabi JF, Adedokun MA, Akinpelu AO, Oyegunle OO, Etafo J, Dede AO, Onyechi MN, Ireneh MU, Gbenga-Ayeni O, Fadiminiyi KG, Ehigbor PI, Ouattara E, Levy-Marchal C, Karcher S, N'guessan-Koffi L, Ahyi I, Amani E, Diabaté M, Siloué B, Schaeffer J, Augier A, Ogbaini-Emovon E, Salam AP, Horby P, Ahmed LA, Günther S, Adedosu AN, Anglaret X, Ayodeji OO, Malvy D. Duvignaud A, et al. Among authors: etafo j. Travel Med Infect Dis. 2020 Jul-Aug;36:101557. doi: 10.1016/j.tmaid.2020.101557. Epub 2020 Jan 21. Travel Med Infect Dis. 2020. PMID: 31978611 Free PMC article.